Quick B-12 Energy Burst 1000 mcg
90/100
This product looks safe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 67% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
1 MicroLingual(R) Tablet(s)
Serving Size
100
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Supplement Facts — Evidence Check
1 mg
(5% DV)
✅ Within RDA (0.1× RDA of 14 mg)
📚 193 studies (Tier A: 5, B: 63)
1000 mcg
(16670% DV)
📊 416.7× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
Proprietary Blend (Combination)
18 mg
Other Ingredients
Lactose
Natural Flavors
Acacia
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Directions: As a dietary supplement, dissolve one MicroLingual tablet under the tongue daily. This product may also be swallowed.
Place on or under the tongue
🧪 Formulation Notes
Preservative free
Additional Information
No shot
Our proprietary hydrodrying process results in fewer inactive binders and fillers and a higher ration of nutritional ingredients - hence the small size. They efficiently provide your body with the nutrients you need right now.
Note: Tablet color may vary from light pink to red. Potency is not affected by this natural variance.
"Less is more" Simplicity Purity Efficiency No pills to swallow
Dissolves immediately on contact
Made in USA
Product Details
DSLD Entry Date
2017-02-24
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Superior Source
DSLD ID
70986
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100